ID   XANQ_ECOLI              Reviewed;         466 AA.
AC   P67444; Q2M9V8; Q46815;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   04-DEC-2007, sequence version 2.
DT   15-FEB-2017, entry version 100.
DE   RecName: Full=Xanthine permease XanQ;
GN   Name=xanQ; Synonyms=ygfO; OrderedLocusNames=b2882, JW2850;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [3]
RP   FUNCTION, ENZYME REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   SUBCELLULAR LOCATION.
RC   STRAIN=K12;
RX   PubMed=16096267; DOI=10.1080/09687860500092927;
RA   Karatza P., Frillingos S.;
RT   "Cloning and functional characterization of two bacterial members of
RT   the NAT/NCS2 family in Escherichia coli.";
RL   Mol. Membr. Biol. 22:251-261(2005).
RN   [4]
RP   TOPOLOGY [LARGE SCALE ANALYSIS].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=15919996; DOI=10.1126/science.1109730;
RA   Daley D.O., Rapp M., Granseth E., Melen K., Drew D., von Heijne G.;
RT   "Global topology analysis of the Escherichia coli inner membrane
RT   proteome.";
RL   Science 308:1321-1323(2005).
RN   [5]
RP   MUTAGENESIS OF PRO-421; SER-423; ILE-424; TYR-425; LEU-427; ASN-430;
RP   ILE-432 AND GLY-436.
RC   STRAIN=K12;
RX   PubMed=18359771; DOI=10.1074/jbc.M800261200;
RA   Papakostas K., Georgopoulou E., Frillingos S.;
RT   "Cysteine-scanning analysis of putative helix XII in the YgfO xanthine
RT   permease: ILE-432 and ASN-430 are important.";
RL   J. Biol. Chem. 283:13666-13678(2008).
RN   [6]
RP   MUTAGENESIS OF HIS-31; ASN-93; LYS-164; ASP-232; GLN-258; GLU-272;
RP   ASP-304 AND ARG-385.
RC   STRAIN=K12;
RX   PubMed=19581302; DOI=10.1074/jbc.M109.030734;
RA   Karena E., Frillingos S.;
RT   "Role of intramembrane polar residues in the YgfO xanthine permease:
RT   HIS-31 and ASN-93 are crucial for affinity and specificity, and ASP-
RT   304 and GLU-272 are irreplaceable.";
RL   J. Biol. Chem. 284:24257-24268(2009).
CC   -!- FUNCTION: Specific, proton motive force-dependent high-affinity
CC       transporter for xanthine. {ECO:0000269|PubMed:16096267}.
CC   -!- ENZYME REGULATION: Inhibited by CCCP and N-ethylmaleimide.
CC       {ECO:0000269|PubMed:16096267}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4.2 uM for xanthine {ECO:0000269|PubMed:16096267};
CC         Vmax=6.36 nmol/min/mg enzyme {ECO:0000269|PubMed:16096267};
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane
CC       {ECO:0000269|PubMed:16096267}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:16096267}.
CC   -!- SIMILARITY: Belongs to the xanthine/uracil permease family.
CC       Nucleobase:cation symporter-2 (NCS2) (TC 2.A.40) subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA83063.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U28375; AAA83063.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U00096; AAC75920.2; -; Genomic_DNA.
DR   EMBL; AP009048; BAE76948.1; -; Genomic_DNA.
DR   PIR; B65072; B65072.
DR   RefSeq; NP_417358.2; NC_000913.3.
DR   RefSeq; WP_001280192.1; NZ_CP014272.1.
DR   ProteinModelPortal; P67444; -.
DR   BioGrid; 4261448; 20.
DR   STRING; 511145.b2882; -.
DR   TCDB; 2.A.40.4.3; the nucleobase/ascorbate transporter (nat) or nucleobase:cation symporter-2 (ncs2) family.
DR   PaxDb; P67444; -.
DR   PRIDE; P67444; -.
DR   DNASU; 949075; -.
DR   EnsemblBacteria; AAC75920; AAC75920; b2882.
DR   EnsemblBacteria; BAE76948; BAE76948; BAE76948.
DR   GeneID; 949075; -.
DR   KEGG; ecj:JW2850; -.
DR   KEGG; eco:b2882; -.
DR   PATRIC; 32121174; VBIEscCol129921_2975.
DR   EchoBASE; EB2877; -.
DR   EcoGene; EG13065; xanQ.
DR   eggNOG; ENOG4105C2W; Bacteria.
DR   eggNOG; COG2233; LUCA.
DR   HOGENOM; HOG000038198; -.
DR   InParanoid; P67444; -.
DR   KO; K16346; -.
DR   OMA; EGPAYLQ; -.
DR   PhylomeDB; P67444; -.
DR   BioCyc; EcoCyc:YGFO-MONOMER; -.
DR   BioCyc; MetaCyc:YGFO-MONOMER; -.
DR   PRO; PR:P67444; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:EcoCyc.
DR   GO; GO:0005886; C:plasma membrane; IDA:EcoCyc.
DR   GO; GO:0042907; F:xanthine transmembrane transporter activity; IDA:EcoCyc.
DR   GO; GO:0042906; P:xanthine transport; IDA:EcoCyc.
DR   InterPro; IPR006042; Xan_ur_permease.
DR   InterPro; IPR006043; Xant/urac/vitC.
DR   Pfam; PF00860; Xan_ur_permease; 1.
DR   TIGRFAMs; TIGR00801; ncs2; 1.
DR   PROSITE; PS01116; XANTH_URACIL_PERMASE; 1.
PE   1: Evidence at protein level;
KW   Cell inner membrane; Cell membrane; Complete proteome; Membrane;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    466       Xanthine permease XanQ.
FT                                /FTId=PRO_0000165965.
FT   TOPO_DOM      1     25       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     26     46       Helical. {ECO:0000255}.
FT   TOPO_DOM     47     55       Periplasmic. {ECO:0000255}.
FT   TRANSMEM     56     76       Helical. {ECO:0000255}.
FT   TOPO_DOM     77     80       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     81    101       Helical. {ECO:0000255}.
FT   TOPO_DOM    102    120       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    121    141       Helical. {ECO:0000255}.
FT   TOPO_DOM    142    151       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    152    172       Helical. {ECO:0000255}.
FT   TOPO_DOM    173    180       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    181    201       Helical. {ECO:0000255}.
FT   TOPO_DOM    202    210       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    211    231       Helical. {ECO:0000255}.
FT   TOPO_DOM    232    258       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    259    279       Helical. {ECO:0000255}.
FT   TOPO_DOM    280    298       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    299    319       Helical. {ECO:0000255}.
FT   TOPO_DOM    320    342       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    343    363       Helical. {ECO:0000255}.
FT   TOPO_DOM    364    364       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    365    384       Helical. {ECO:0000255}.
FT   TOPO_DOM    385    425       Periplasmic. {ECO:0000255}.
FT   TRANSMEM    426    446       Helical. {ECO:0000255}.
FT   TOPO_DOM    447    466       Cytoplasmic. {ECO:0000255}.
FT   SITE         31     31       Essential for affinity and specificity.
FT   SITE         93     93       Essential for affinity and specificity.
FT   SITE        272    272       Essential for purine uptake.
FT   SITE        304    304       Essential for purine uptake.
FT   SITE        430    430       Important for purine uptake and affinity.
FT   SITE        432    432       Important for purine uptake and affinity.
FT   MUTAGEN      31     31       H->C,L: Decrease in activity.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN      31     31       H->K,R: Strong decrease in activity.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN      31     31       H->N: No change in activity.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN      31     31       H->Q: Increase of activity.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN      93     93       N->A: Highly active.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN      93     93       N->C,D,T: Strong decrease in activity.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN      93     93       N->Q: Loss of activity.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN      93     93       N->S: Increase of activity.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN     164    164       K->C,R: Highly active.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN     232    232       D->C: Decrease in activity.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN     232    232       D->E: Highly active.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN     258    258       Q->C: Decrease in activity.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN     258    258       Q->N: Highly active.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN     272    272       E->C: Loss of activity.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN     272    272       E->D: Strong decrease in activity.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN     304    304       D->C: Loss of activity.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN     304    304       D->E: Strong decrease in activity.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN     385    385       R->C: Decrease in activity.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN     385    385       R->K: Highly active.
FT                                {ECO:0000269|PubMed:19581302}.
FT   MUTAGEN     421    421       P->C: Strong decrease in activity.
FT                                {ECO:0000269|PubMed:18359771}.
FT   MUTAGEN     421    421       P->G: Highly active.
FT                                {ECO:0000269|PubMed:18359771}.
FT   MUTAGEN     423    423       S->C: Highly active.
FT                                {ECO:0000269|PubMed:18359771}.
FT   MUTAGEN     424    424       I->C: Highly active.
FT                                {ECO:0000269|PubMed:18359771}.
FT   MUTAGEN     425    425       Y->C: Strong decrease in activity.
FT                                {ECO:0000269|PubMed:18359771}.
FT   MUTAGEN     427    427       L->C: Decrease in activity.
FT                                {ECO:0000269|PubMed:18359771}.
FT   MUTAGEN     430    430       N->T: Loss of activity.
FT                                {ECO:0000269|PubMed:18359771}.
FT   MUTAGEN     432    432       I->A,S,T,V: Strong decrease in activity.
FT                                {ECO:0000269|PubMed:18359771}.
FT   MUTAGEN     432    432       I->L,M,E,F: Loss of activity.
FT                                {ECO:0000269|PubMed:18359771}.
FT   MUTAGEN     432    432       I->N,Q: Highly active.
FT                                {ECO:0000269|PubMed:18359771}.
FT   MUTAGEN     436    436       G->C: Highly active.
FT                                {ECO:0000269|PubMed:18359771}.
SQ   SEQUENCE   466 AA;  49108 MW;  95EAFB06FEEE9175 CRC64;
     MSDINHAGSD LIFELEDRPP FHQALVGAIT HLLAIFVPMV TPALIVGAAL QLSAETTAYL
     VSMAMIASGI GTWLQVNRYG IVGSGLLSIQ SVNFSFVTVM IALGSSMKSD GFHEELIMSS
     LLGVSFVGAF LVVGSSFILP YLRRVITPTV SGIVVLMIGL SLIKVGIIDF GGGFAAKSSG
     TFGNYEHLGV GLLVLIVVIG FNCCRSPLLR MGGIAIGLCV GYIASLCLGM VDFSSMRNLP
     LITIPHPFKY GFSFSFHQFL VVGTIYLLSV LEAVGDITAT AMVSRRPIQG EEYQSRLKGG
     VLADGLVSVI ASAVGSLPLT TFAQNNGVIQ MTGVASRYVG RTIAVMLVIL GLFPMIGGFF
     TTIPSAVLGG AMTLMFSMIA IAGIRIIITN GLKRRETLIV ATSLGLGLGV SYDPEIFKIL
     PASIYVLVEN PICAGGLTAI LLNIILPGGY RQENVLPGIT SAEEMD
//
